Show simple item record

dc.contributor.authorPavlech, Laura L.
dc.contributor.authorGianturco, Stephanie L.
dc.contributor.authorStorm, Kathena D.
dc.contributor.authorYuen, Melissa V.
dc.contributor.authorMattingly, Ashlee N.
dc.descriptionThe University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI), in collaboration with the Food and Drug Administration (FDA), conducted research and outreach to solicit input from the public, including medical specialists, to better understand the use of certain bulk drug substances nominated for use in compounding by outsourcing facilities under section 503B of the Federal Food, Drug, and Cosmetic Act (the Act). In particular, we were interested in how drugs compounded with these bulk drug substances were used historically, and how they are currently used in clinical practice. The research will assist the FDA in its development of a list of bulk drug substances that outsourcing facilities can use in compounding under section 503B of the Act. Research for each bulk drug substance included a systematic literature review, interviews with medical experts and a survey of healthcare practitioners. Our findings for the nominated substance, Potassium chloride, were summarized in this report.en_US
dc.description.sponsorshipU.S. Food and Drug Administration clinical use of bulk drug substances nominated for inclusion on the 503B Bulks List Grant number: #U01FD005946en_US
dc.rightsAttribution-NoDerivatives 4.0 International*
dc.subjectFood, Drug and Cosmetic Acten_US
dc.subjectFood, Drug and Cosmetic Act, Section 503Ben_US
dc.subjectFood and Drug Administrationen_US
dc.subjectOutsourcing facilityen_US
dc.subject.meshPotassium Chlorideen_US
dc.subject.meshDrug Compoundingen_US
dc.subject.meshLegislation, Drugen_US
dc.subject.meshUnited States Food and Drug Administrationen_US
dc.titlePotassium chloride: Summary Reporten_US

Files in this item

Potassium chloride_Final_2021_ ...
Final report

This item appears in the following Collection(s)

Show simple item record

Attribution-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NoDerivatives 4.0 International